Pathologic validation of an yttrium-90 trans-arterial radioembolization dosimetry: a case report

Yttrium-90 (Y-90) trans-arterial radioembolization (TARE) is used in the management of unresectable hepatocellular carcinoma (HCC). During the last 5 years, dosimetry software has been developed to allow for a more rigorous approach of dose prescription in Y-90 TARE. We present here a case study of...

Descripción completa

Detalles Bibliográficos
Autores principales: Baikovitz, Jacqueline B, Thornton, Lindsay, Garcia-Buitrago, Monica T, Livingstone, Alan S, Studenski, Matthew T, Portelance, Lorraine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088287/
https://www.ncbi.nlm.nih.gov/pubmed/33959251
http://dx.doi.org/10.1093/jscr/rjab078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088287/
https://www.ncbi.nlm.nih.gov/pubmed/33959251
http://dx.doi.org/10.1093/jscr/rjab078

Ejemplares similares